A number of research firms have changed their ratings and price targets for AtriCure (NASDAQ: ATRC): 10/6/2015 – AtriCure had its price target lowered by analysts at Needham & Company LLC from $32.00 to $30.00. They now have a “buy” rating on the stock. 10/6/2015 – AtriCure had its “buy” rating reaffirmed by analysts at […]
